MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Bio-Rad Laboratories Long-Term Debt 2011-2026 | BIO
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Bio-Rad Laboratories
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 B | 1.2 B | 1.2 B | 10.5 M | 1.8 M | 13.6 M | 439 M | 435 M | 434 M | 436 M | 436 M | 436 M | 732 M | 732 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.2 B | 1.8 M | 550 M |
Quarterly Long-Term Debt Bio-Rad Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | 1.2 B | - | 1.2 B | 10.5 M | 10.6 M | 10.8 M | 10.9 M | 12.3 M | 12.2 M | 12.3 M | 12.3 M | 13.6 M | 438 M | 13.6 M | 13.6 M | 439 M | 439 M | 439 M | 439 M | 435 M | 435 M | 435 M | 435 M | 434 M | 434 M | 434 M | 434 M | 434 M | 434 M | 434 M | 434 M | 436 M | 436 M | 436 M | 436 M | 436 M | 436 M | 733 M | 436 M | 732 M | 732 M | 732 M | 732 M | 732 M | 732 M | 732 M | 732 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.2 B | 10.5 M | 552 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
88.2 M | $ 176.83 | 5.97 % | $ 13.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
501 M | $ 11.66 | 5.71 % | $ 1.75 B | USA |
 |
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
32.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
AxoGen
AXGN
|
48.4 M | $ 34.0 | 9.71 % | $ 1.57 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.72 B | $ 12.18 | 2.01 % | $ 1.65 B | USA |
 |
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.11 M | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
17.1 M | - | -0.97 % | $ 54.4 M | USA |
 |
Bruker Corporation
BRKR
|
2.06 B | $ 38.25 | 4.31 % | $ 5.7 K | USA |
 |
GBS
GBS
|
1.65 M | - | -0.57 % | $ 7.12 M | USA |
 |
Boston Scientific Corporation
BSX
|
11.1 B | $ 62.56 | 1.15 % | $ 92.6 B | USA |
 |
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
1.1 M | $ 24.4 | 2.61 % | $ 206 M | USA |
 |
ClearPoint Neuro
CLPT
|
49.1 M | $ 9.17 | 1.1 % | $ 260 M | USA |
 |
Globus Medical
GMED
|
436 K | $ 91.96 | 2.13 % | $ 12.4 B | USA |
 |
CryoLife, Inc.
CRY
|
290 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | USA |
 |
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
7.56 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
3.59 M | - | 1.37 % | $ 20.5 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
154 K | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
38.6 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
7.64 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
20.4 M | $ 4.14 | 2.22 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
63.6 M | - | - | $ 955 M | USA |
 |
Nevro Corp.
NVRO
|
188 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
16.7 M | $ 0.62 | 1.67 % | $ 38.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
2 M | $ 3.37 | -0.88 % | $ 126 M |  France |
 |
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
835 K | $ 9.85 | 1.86 % | $ 353 M | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
834 M | $ 36.59 | 5.94 % | $ 1.14 B | USA |
 |
FONAR Corporation
FONR
|
155 K | $ 18.62 | 0.22 % | $ 122 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
598 M | $ 81.71 | 1.08 % | $ 47.8 B | USA |
 |
Inspire Medical Systems
INSP
|
30 M | $ 53.38 | -1.89 % | $ 1.57 B | USA |
 |
Varex Imaging Corporation
VREX
|
366 M | $ 11.04 | 4.25 % | $ 457 M | USA |
 |
Helius Medical Technologies
HSDT
|
12 K | $ 1.88 | 2.73 % | $ 1.14 M | USA |
 |
Inogen
INGN
|
14.3 M | $ 6.67 | -1.91 % | $ 177 M | USA |
 |
IRIDEX Corporation
IRIX
|
98 K | $ 1.03 | - | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.19 B | $ 87.48 | 2.78 % | $ 3.04 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
99.8 M | $ 16.01 | 1.59 % | $ 376 M | USA |